Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
Rising from the Fall
Catastrophic Case Management Meet Carolyn Lau, MBA, RN, CCM Carolyn Lau is a seasoned catastrophic
Mitchell’s Plan to Address Michigan SB1 No-Fault Legislation for Bill Review
Mitchell has developed a four-step plan to address Michigan SB1 for bill review applications.
Virtual Connections: Utilizing Technology to Build and Deepen Relationships with Injured Workers
As the telemedicine industry continues to boom we’re seeing more and more new forms of telehealth emerge in the marketplace. Variations including tele-rehab, remote patient monitoring and even “avatar-like” nurses being utilized by hospital systems and providers. In this new world of telehealth we need to constantly be looking for innovative modes by which triage and telephonic case managers can connect with the individuals they serve and engage them on their road to recovery. At Coventry we are piloting two new types of Virtual Connections designed to support our clinical staff in the establishment of trust and engagement with injured workers – Virtual Triage and Video-Telephonic Case Management.
FDA Approves Generic Lyrica Pregabalin
One of the most talked-about drug patents in workers' compensation, Pfizer's Lyrica (pregabalin), patent extensions ended on July 1, 2019.
Mitchell Announces Partnership with Drew Technologies to Deliver OEM Scanning and Remote Diagnostic Support
Enhancements from Drew extend Mitchell Diagnostics' (MD) industry-leading product suite capabilities for collision repairers with new MD-OEM option.
StateWatch: Bill Review July 2019
Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the bill review services Genex provides.